Reem Karmali

55PUBLICATIONS
262CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Oct 30, 2026
Comparative survival and time toxicity outcomes of CAR-T versus bispecific antibody therapies in relapsed/refractory FL.

|Oct 27, 2026
Navigating T-Cell-Directed Therapies in Transformed Follicular Lymphoma.

|Sep 24, 2026
Risk factors for CRS and ICANS with Bispecific Antibodies for Aggressive Lymphomas.

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Aug 20, 2026
Second Line CD19 CAR-T vs Platinum Salvage and Autologous Stem Cell Transplant for Primary Mediastinal B-Cell Lymphoma.

|Apr 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Pageof 10

Frequent Collaborators

22 joint publications

Narendranath Epperla

17 joint publications

Leo I Gordon

15 joint publications

Jonathon Cohen

14 joint publications

Natalie Sophia Grover